Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
550k contract. EC will be happy today.
Time to buy some back imo
EC
"A leading liquid biopsy Company with an FDA cleared machine, contracts with both Eisai and now Astrazeneca........"
Really EC are you sure Parsortix is FDA "cleared" and there are contracts with both AZ and Eisai...these are tiny of little monetary value and for trial purposes only and may never lead anywhere..the way your misrepresenting information is appalling!
Yes it spiked at 37p for a few hours and held 31p for a good while in Jan
Director bought at 28p last year.
Mesquida.
"Surely 37p was the top ofbthe January spoke ?2
======================================
Sorry. My memory said 51p but checking the chart it was arounf 31p! Still over two fold the currect sp of course.
Surely 37p was the top ofbthe January spoke ?
Nudgesta.
"The sp has never been that low??"
======================
Results due this month.
Lowest I remember was about 9.8p Nov 2023. Highest since then 51p ish (spike up due to RNS of 4th Jan 2024 - Cancer breakthrough). Recently spiked to 17p (contract with Astrazeneca). Illiquid share means it moves a lot on low volume (either way). Thus a good news RNS often spikes the sp up a lot.......
Currently 14p.
All IMHO.
The sp has never been that low??
I would not be surprised is a bid comes in.
A leading liquid biopsy Company with an FDA cleared machine, contracts with both Eisai and now Astrazeneca........
The market cap is ridiculous if you ask me.
All IMHO.
Due this month.
The original announcement "ANGLE announces partnership with BioView" 19th April 2023:-
https://www.lse.co.uk/rns/AGL/angle-announces-partnership-with-bioview-dvvtkgt3ttabibt.html
The update "Parsortix HER2 assay showcased at AACR 2024" 8th April 2024:
https://www.lse.co.uk/rns/AGL/parsortix-her2-assay-showcased-at-aacr-2024-4k393y7ivsvtwno.html
Lovely. Need the share price to drop to 6-7p. I will then load up more like TwoGood2.
I will bring some flowers and give my condolences 🙏 ☹️!
Due this month - May 2024.
See:-
https://angleplc.com/information-for-investors-angle-plc/financial-reports/#text_grid-1
Yes they were shocking...I did say a placement was on the cards.. imho.
????
I was thinking 10p at best!
TwoGood2Die.
I don't mean for the whole Company. LOL!
Hello.
Pretty obvious the market doesn't agree with the desperate rampers here!
Https://www.lse.co.uk/ShareBrokerTips.html?shareprice=AGL&share=Angle
Slowly all pharma's are getting delisted as they are under valued. Redx got delisted yesterday. Dyor
Also looks like seller out. This should now move. Also trading update coming any day. Dyor
Broker Rating 70p. What's not to like.
And 474 parsortix blood samples analysed so at least £474k in the coffers….
Https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.34978
Just look at the Companies mentioned in this article:-
***Elena Ioana Braicu receives research funding from Bayer, Roche Diagnostics, Tesaro, GSK, and AstraZeneca and personal fees from AstraZeneca, Clovis, GSK, Tesaro, EISAI, RochePharma, and Roche Diagnostics. Elena Ioana Braicu is a Feodor Lynen fellow of the Humboldt Foundation and a participant in the Charité Clinical Scientist Program funded by the Charité Universitätsmedizin Berlin and the Berlin Institute of Health.
***Philipp Harter receives research funding from Astra Zeneca, Roche, GSK, Genmab, DFG, European Union, DKH, Immunogen, Seagen, Clovis, and Novartis and honoraria from Amgen, Astra Zeneca, GSK, Roche, Sotio, Stryker, Zai Lab, MSD, Clovis, Eisai, Mersana, and Exscientia.
***Philipp Harter is ******an advisory board member******* for Astra Zeneca, Roche, GSK, Clovis, Immunogen, MSD, Miltenyi, Novartis, and Eisai!!!!!!!!!!!!!!!*************.
All IMHO.